Andrea Pederzolli

Vorsitzender bei

Laboratori Italiani Riuniti SpA

Finance

Health Technology

Commercial Services

Profil

Andrea Pederzolli is currently the Chairman at Laboratori Italiani Riuniti SpA since 2020.
Prior to this, he worked as a Fund Manager at Xyence Capital SGR from 2017 to 2021 and as a Director at Enterome SA.

Aktive Positionen von Andrea Pederzolli

Unternehmen	Position	Beginn
Laboratori Italiani Riuniti SpA Laboratori Italiani Riuniti SpA Miscellaneous Commercial ServicesCommercial Services Operates as an analysis laboratory	Vorsitzender	01.02.2020

Alle aktiven Positionen von Andrea Pederzolli

Ehemalige bekannte Positionen von Andrea Pederzolli

Unternehmen	Position	Ende
Xyence Capital SGR SpA Xyence Capital SGR SpA Investment ManagersFinance Xyence Capital invests in startup companies located in europe the United States and Italy. The firm targets companies operating in the field of electronic and health technology sector with particular focus in biotechnology and IT services. It provides equity for early to later stage as well as growth capital requirements with invests between EUR 0.5 to EUR 24 million.	Private Equity Investor	01.05.2021
Enterome SA Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Andrea Pederzolli im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Andrea Pederzolli im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	3
Xyence Capital SGR SpA Xyence Capital SGR SpA Investment ManagersFinance Xyence Capital invests in startup companies located in europe the United States and Italy. The firm targets companies operating in the field of electronic and health technology sector with particular focus in biotechnology and IT services. It provides equity for early to later stage as well as growth capital requirements with invests between EUR 0.5 to EUR 24 million.	Finance
Enterome SA Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer	Health Technology
Laboratori Italiani Riuniti SpA Laboratori Italiani Riuniti SpA Miscellaneous Commercial ServicesCommercial Services Operates as an analysis laboratory	Commercial Services